Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2

Autor:	Ulrich J M, Mey, Wolfram, Brugger, Heike, Schwarb, Stefanie, Pederiva, Andreas, Schwarzer, Tobias, Dechow, Paul, Jehner, Jacqueline, Rauh, Christian J, Taverna, Mathias, Schmid, Martin, Schmidt-Hieber, Steffen, Doerfel, Natalie, Fischer, Axel, Ruefer, Carsten, Ziske, Wolfgang, Knauf, Richard, Cathomas, Roger, von Moos, Felicitas, Hitz, Rafael, Sauter, Elke, Hiendlmeyer, Nathan, Cantoni, Mario, Bargetzi, Christoph, Driessen
Rok vydání:	2016
Předmět:	Aged 80 and over Salvage Therapy Neutropenia Remission Induction Middle Aged Thrombocytopenia Dexamethasone Thalidomide Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Bendamustine Hydrochloride Humans Multiple Myeloma Lenalidomide Aged
Zdroj:	British journal of haematology. 176(5)
ISSN:	1365-2141
Popis:	The combination of lenalidomide (Revlimid
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::21bd4d26e7d63ff83dec157b4d467887 https://pubmed.ncbi.nlm.nih.gov/27983764 Zobrazit plný text záznamu Plný text